Back to UBS Group AG UBS Group AG

NRXPNRXP
Showing 8 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in NRX PHARMACEUTICALS INC

UBS Group AG holds 423,115 shares of NRXP (NRX PHARMACEUTICALS INC), worth $1.7M as of 2026-Q2. The position was increased (+1577.2% shares). NRXP represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.7M

Current Shares

423,115

Total Value Change

+$1.7M

Total Shares Change

+423,077

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
423,115
+1577.2%
$1.7M0.0%$4.09
41
2026-Q1
Increased
25,227
+613.0%
$53,7340.0%$1.80
23
2025-Q4
Decreased
3,538
-97.7%
$9,5880.0%$2.63
0
2025-Q3
Increased
152,848
+25.7%
$504,3990.0%$3.25
30
2025-Q2
Increased
121,608
+1157x
$396,4420.0%$3.42
38
2025-Q1
Decreased
105
-30.0%
$2150.0%$2.03
0
2024-Q4
Increased
150
+294.7%
$3300.0%$1.53
12
2024-Q3
Decreased
38
-96.5%
$640.0%$1.75
0

Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used